Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology, shared a post on X:
“The actionable transcriptome in precision oncology (NatureRevClinOncol)! RNA-seq is moving from “nice to have” to clinically actionable: RNA-seq captures actionable biology beyond DNA Detects fusions, splice variants and expression-driven targets Identifies overexpression of oncogenes and underexpression of tumor suppressors DNA tells you what’s altered (RNA tells you what’s active).”
Title: The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Authors: Amber Johnson, Yifei Shen, Xiaofeng Zheng, Fei Su, Jia Zeng, Burak Uzunparmak, Eun-Kyoung Breuer, Vijaykumar Holla, Michael Kahle, Sun-Hee Kim, Thuy Vu, Kenna R. Mills Shaw, Ecaterina Ileana Dumbrava, Timothy A. Yap, Jordi Rodon, Mark Routbort, Keyur Patel, Shashikant Kulkarni, Donna Hansel, Julian Bryan, Anil Korkut, Ken Chen, Funda Meric-Bernstam
Read The Full Article
More posts featuring Mario Balsa on OncoDaily.
